Vendor, Durham, NC
Eydis Bio, Inc.
UEI MWWCM7JMBCF1, CAGE 88U01
1 award and $2,486,010 obligated between September 29, 2025 and October 21, 2026, 100% under full and open competition, against 1.0 offers on average where reported. 12 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $2,486,010 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Hear when Eydis Bio, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Eydis Bio, Inc.'s contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to National Institutes of Health, by dollars.
| Fisher Bioservices Inc.Rockville, MD | $101,554,099 |
| PPD Development LPWilmington, NC | $65,307,629 |
| Seattle Children'S HospitalSeattle, WA | $61,525,979 |
| Alpha Genesis Inc.Yemassee, SC | $55,645,143 |
| Psychogenics Inc.Paramus, NJ | $36,035,836 |
| Rho Federal Systems Division Inc.Durham, NC | $35,268,211 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93025C00040Definitive Contract, September 29, 2025, Full and Open Competition After Exclusion of Sources, 1 offersSolicitation | National Institutes of Health NiaidNational Institutes of Health | Perform a Structure Activity Relationship (Sar), Molecular Binding and Metabolism of the Lead Scaffold (HS-176) to Guide the Development of NAICS 541714, PSC AN12 | $2,486,010 |
- Places of performance
- North Carolina
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 3 across 1 awards